Nektar Therapeutics Files Prospectus for Stock Offering
Ticker: NKTR · Form: 424B5 · Filed: Apr 23, 2026 · CIK: 0000906709
| Field | Detail |
|---|---|
| Company | Nektar Therapeutics (NKTR) |
| Form Type | 424B5 |
| Filed Date | Apr 23, 2026 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: prospectus, stock-offering, equity-raise
Related Tickers: NKTR
TL;DR
Nektar Therapeutics is filing to sell more stock, details to come.
AI Summary
Nektar Therapeutics filed a 424B5 prospectus on April 23, 2026, detailing the terms of a public offering. The filing indicates the company is offering shares of its common stock, with specific details on the number of shares and the price to be determined at the time of the offering. This is a standard regulatory filing to update the market on potential equity offerings.
Why It Matters
This filing signals Nektar Therapeutics' intent to raise capital through a public stock offering, which could impact its financial structure and future development plans.
Risk Assessment
Risk Level: medium — Prospectus filings for stock offerings can indicate a need for capital, which may stem from operational challenges or strategic investments, carrying inherent risks for investors.
Key Numbers
- 424B5 — Form Type (Indicates a prospectus relating to a delayed offering or shelf registration)
Key Players & Entities
- Nektar Therapeutics (company) — Filer of the prospectus
- 0000906709 (company) — CIK number for Nektar Therapeutics
- 2026-04-23 (date) — Filing date of the 424B5 prospectus
- 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 (address) — Mailing and Business Address for Nektar Therapeutics
FAQ
What is the purpose of the 424B5 filing by Nektar Therapeutics?
The 424B5 filing is a prospectus that provides details about a public offering of Nektar Therapeutics' common stock.
When was this prospectus filed with the SEC?
The prospectus was filed on April 23, 2026.
What is the CIK number for Nektar Therapeutics?
The CIK number for Nektar Therapeutics is 0000906709.
Where is Nektar Therapeutics located?
Nektar Therapeutics' mailing and business address is 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158.
What type of securities is Nektar Therapeutics offering?
The filing indicates an offering of shares of its common stock.
Filing Details
This Form 424B5 (Form 424B5) was filed with the SEC on April 23, 2026 regarding NEKTAR THERAPEUTICS (NKTR).